Jane Lynch - Concepedia

Author

Jane Lynch

The University of Texas Health Science Center at San Antonio

Also Known As

Aniko Nowakowski, Blangero, John, Cogen F, D.R. Word, Irene N. Sills, J. L. Lynch, J. Lynch, JANE L. LYNCH, Jane L Lynch, Jane L. Lynch

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio George Washington University University of Colorado Anschutz Medical Campus Children's Hospital Colorado University of Colorado Denver

About

Jane Lynch is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	8	316
2	Diabetes	4	5	245
3	Public Health	3	3	71
4	Health Sciences	1	1	98
5	Endocrinology	1	1	14

Jane Lynch

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Liraglutide in Children and Adolescents with Type 2 Diabetes William V. Tamborlane, Margarita Barrientos‐Pérez, Udi Fainberg, New England Journal of Medicine	2019	333
Evaluating Children With Fractures for Child Physical Abuse Emalee G. Flaherty, Jeannette M. Pérez-Rosselló, Michael A. Levine, PEDIATRICS	2014	284
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort Zhuo Chen, Miao Feng, Andrew D. Paterson, Proceedings of the National Academy of Sciences	2016	238
Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study Petter Bjornstad, Lori M. Laffel, Jane Lynch, Diabetes Care	2019	113
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Jonathan Q. Purnell, Barbara H. Braffett, Bernard Zinman, Diabetes Care	2017	112
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith, The Lancet Diabetes & Endocrinology Metabolic SyndromeDiabetes ManagementYoung PeopleCardiovascular DiseaseInsulin Management	2023	98
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial Petter Bjornstad, Edward Nehus, Laure El ghormli, American Journal of Kidney Diseases ObesityMetabolic SyndromeInsulin SensitivityRenal DiseaseDiabetes Epidemiology	2017	88
Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study Fida Bacha, Laura Pyle, Kristen J. Nadeau, Pediatric Diabetes	2012	50
Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States Praveen Kumar Conjeevaram Selvakumar, Mohammad Nasser Kabbany, Rocío López, Journal of Pediatric Gastroenterology and Nutrition	2018	50
Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes Petter Bjornstad, Kara S. Hughan, Megan M. Kelsey, Diabetes Care	2019	49

Page 1